Table 3 Local and systemic adjuvant therapy by histologic type
From: Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
| Â | Histologic type | Â | |
|---|---|---|---|
Therapy | ILC | IDC | P |
Surgery | Â | Â | Â |
   Number of patients | 4197 | 45995 |  |
   None (%) | 1.1 | 0.8 |  |
   Modified radical mastectomy (%) | 89.4 | 86.5 | <0.0001 |
   Lumpectomy (%) | 9.5 | 12.7 |  |
Adjuvant therapy | Â | Â | Â |
   Number of patients | 2817 | 31043 |  |
   None (%) | 42.4 | 42.3 |  |
   Chemotherapy (%) | 16.2 | 23.7 | <0.0001 |
   Endocrine therapy (%) | 28.8 | 22.9 |  |
   Chemotherapy and endocrine therapy (%) | 12.6 | 11.1 |  |